Renaissance Technologies - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 1 filers reported holding TREVI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$147
-31.0%
67,300
-24.6%
0.00%
Q2 2023$213
-51.5%
89,300
-62.4%
0.00%
-100.0%
Q1 2023$439
-28.5%
237,400
-25.3%
0.00%0.0%
Q4 2022$614
-99.9%
318,000
-24.1%
0.00%0.0%
Q3 2022$646,000
+51.6%
419,187
+176.7%
0.00%0.0%
Q2 2022$426,000
+67.1%
151,500
+30.6%
0.00%
Q1 2022$255,000
-3.4%
116,000
-65.6%
0.00%
Q4 2021$264,000
+187.0%
337,400
+415.1%
0.00%
Q3 2021$92,000
-55.8%
65,500
-29.3%
0.00%
Q2 2021$208,000
-37.0%
92,600
-24.0%
0.00%
Q1 2021$330,000
+432.3%
121,849
+374.1%
0.00%
Q4 2020$62,00025,7000.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,375,907$9,053,0002.48%
NEA Management Company, LLC 5,940,796$39,090,0001.57%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$31,748,0000.56%
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. 70,000$460,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$658,0000.01%
FMR LLC 792,700$5,216,0000.00%
CANADA PENSION PLAN INVESTMENT BOARD 40,000$263,0000.00%
BlackRock Inc. 23,713$155,0000.00%
LPL Financial LLC 10,000$66,0000.00%
JPMORGAN CHASE & CO 3$00.00%
View complete list of TREVI THERAPEUTICS INC shareholders